Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 4, Issue 9
1 September 1998
Issue Cover
All Issues
ISSN 1078-0432
EISSN 1557-3265
Issue Sections

Hypothesis

The relationship between high-dose treatment and combination chemotherapy: the concept of summation dose intensity.
E Frei, 3rd; A Elias; C Wheeler; P Richardson; W Hryniuk
View articletitled, The relationship between high-dose treatment and combination chemotherapy: the concept of summation dose intensity.
Open the PDF for in another window

Advances in Brief

Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas.
R Fety; F Rolland; M Barberi-Heyob; A Hardouin; L Campion; T Conroy; J L Merlin; A Rivière; G Perrocheau; M C Etienne; G Milano
View articletitled, Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas.
Open the PDF for in another window
Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies.
S Schulz; S Schulz; J Schmitt; D Wiborny; H Schmidt; S Olbricht; W Weise; A Roessner; C Gramsch; V Höllt
View articletitled, Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies.
Open the PDF for in another window
Prevention of intestinal toxic effects and intensification of irinotecan's therapeutic efficacy against murine colon cancer liver metastases by oral administration of the lipopeptide JBT 3002.
H Shinohara; J J Killion; H Kuniyasu; R Kumar; I J Fidler
View articletitled, Prevention of intestinal toxic effects and intensification of irinotecan's therapeutic efficacy against murine colon cancer liver metastases by oral administration of the lipopeptide JBT 3002.
Open the PDF for in another window
Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors.
D Siegel; W A Franklin; D Ross
View articletitled, Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors.
Open the PDF for in another window
The effects of local hyperthermia on the catabolism of a radioiodinated chimeric monoclonal antibody.
M L Hauck; M R Zalutsky
View articletitled, The effects of local hyperthermia on the catabolism of a radioiodinated chimeric monoclonal antibody.
Open the PDF for in another window

Research Articles

Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue.
P H Walz; P Björk; P O Gunnarsson; K Edman; B Hartley-Asp
View articletitled, Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue.
Open the PDF for in another window
Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
D H Ho; R Pazdur; W Covington; N Brown; Y Y Huo; Y Lassere; J Kuritani
View articletitled, Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Open the PDF for in another window
In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients.
J Geisler; N King; G Anker; G Ornati; E Di Salle; P E Lønning; M Dowsett
View articletitled, In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients.
Open the PDF for in another window
Phase I study of a five-day dose schedule of 4-Ipomeanol in patients with non-small cell lung cancer.
V K Kasturi; M P Dearing; S C Piscitelli; E K Russell; G G Sladek; K O'Neil; G A Turner; T L Morton; M C Christian; B E Johnson; M J Kelley
View articletitled, Phase I study of a five-day dose schedule of 4-Ipomeanol in patients with non-small cell lung cancer.
Open the PDF for in another window
Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7.
M A Steller; K J Gurski; M Murakami; R W Daniel; K V Shah; E Celis; A Sette; E L Trimble; R C Park; F M Marincola
View articletitled, Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7.
Open the PDF for in another window
Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeks.
S R Alberts; C Erlichman; J M Reid; J A Sloan; M M Ames; R L Richardson; R M Goldberg
View articletitled, Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeks.
Open the PDF for in another window
Effect of neoadjuvant androgen deprivation on circulating prostate cells in the bone marrow of men undergoing radical prostatectomy.
D P Wood, Jr; A Beaman; M Banerjee; I Powell; E Pontes; M L Cher
View articletitled, Effect of neoadjuvant androgen deprivation on circulating prostate cells in the bone marrow of men undergoing radical prostatectomy.
Open the PDF for in another window
Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients.
J Geisler; S B Geisler; P E Lønning; R Smaaland; K M Tveit; H Refsum; P M Ueland
View articletitled, Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients.
Open the PDF for in another window
Tumor angiogenesis and micrometastasis in bone marrow of patients with early gastric cancer.
Y Maehara; S Hasuda; T Abe; E Oki; Y Kakeji; S Ohno; K Sugimachi
View articletitled, Tumor angiogenesis and micrometastasis in bone marrow of patients with early gastric cancer.
Open the PDF for in another window
Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma.
K Kramer; W L Gerald; B H Kushner; S M Larson; M Hameed; N K Cheung
View articletitled, Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma.
Open the PDF for in another window
Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood.
Y Ko; M Klinz; G Totzke; I Gouni-Berthold; A Sachinidis; H Vetter
View articletitled, Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood.
Open the PDF for in another window
Circulating p53 antibodies as early markers of oral cancer: correlation with p53 alterations.
R Ralhan; N Nath; S Agarwal; M Mathur; B Wasylyk; N K Shukla
View articletitled, Circulating p53 antibodies as early markers of oral cancer: correlation with p53 alterations.
Open the PDF for in another window
Specific transcription factors prognostic for prostate cancer progression.
K Aoyagi; I Shima; M Wang; Y Hu; F U Garcia; M E Stearns
View articletitled, Specific transcription factors prognostic for prostate cancer progression.
Open the PDF for in another window
Angiogenin expression and prognosis in primary breast carcinoma.
S Montero; C Guzmán; H Cortés-Funes; R Colomer
View articletitled, Angiogenin expression and prognosis in primary breast carcinoma.
Open the PDF for in another window
Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy.
L Zhang; J W Taub; M Williamson; S C Wong; B Hukku; J Pullen; Y Ravindranath; L H Matherly
View articletitled, Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy.
Open the PDF for in another window
Augmented membrane type 1 matrix metalloproteinase (MT1-MMP):MMP-2 messenger RNA ratio in gastric carcinomas with poor prognosis.
C Caenazzo; M Onisto; L Sartor; R Scalerta; A Giraldo; D Nitti; S Garbisa
View articletitled, Augmented membrane type 1 matrix metalloproteinase (MT1-MMP):MMP-2 messenger RNA ratio in gastric carcinomas with poor prognosis.
Open the PDF for in another window
Expression profile of prostate-specific antigen messenger RNA assessed by in situ hybridization is a novel prognostic marker for patients with untreated prostate cancer.
T Tsurusaki; T Koji; H Sakai; H Kanetake; Y Saito
View articletitled, Expression profile of prostate-specific antigen messenger RNA assessed by in situ hybridization is a novel prognostic marker for patients with untreated prostate cancer.
Open the PDF for in another window
Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas.
Y Kitadai; K Haruma; T Tokutomi; S Tanaka; K Sumii; M Carvalho; M Kuwabara; K Yoshida; T Hirai; G Kajiyama; E Tahara
View articletitled, Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas.
Open the PDF for in another window
UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner.
C T Hsueh; D Kelsen; G K Schwartz
View articletitled, UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner.
Open the PDF for in another window
Photodynamic therapy of naturally occurring tumors in animals using a novel benzophenothiazine photosensitizer.
A E Frimberger; A S Moore; L Cincotta; S M Cotter; J W Foley
View articletitled, Photodynamic therapy of naturally occurring tumors in animals using a novel benzophenothiazine photosensitizer.
Open the PDF for in another window
Interferon-alpha-induced activation of signal transducer and activator of transcription proteins in malignant melanoma.
W E Carson
View articletitled, Interferon-alpha-induced activation of signal transducer and activator of transcription proteins in malignant melanoma.
Open the PDF for in another window
Desensitization and sensitization of cells to fluoropyrimidines with different antisenses directed against thymidylate synthase messenger RNA.
J Ju; S E Kane; H J Lenz; K D Danenberg; E Chu; P V Danenberg
View articletitled, Desensitization and sensitization of cells to fluoropyrimidines with different antisenses directed against thymidylate synthase messenger RNA.
Open the PDF for in another window
Characterization of a novel bispecific antibody that mediates Fcgamma receptor type I-dependent killing of tumor-associated glycoprotein-72-expressing tumor cells.
C Russoniello; C Somasundaram; J Schlom; Y M Deo; T Keler
View articletitled, Characterization of a novel bispecific antibody that mediates Fcgamma receptor type I-dependent killing of tumor-associated glycoprotein-72-expressing tumor cells.
Open the PDF for in another window
Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen.
S P Langdon; H Gabra; J M Bartlett; G J Rabiaz; R A Hawkins; A L Tesdale; A A Ritchie; W R Miller; J F Smyth
View articletitled, Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen.
Open the PDF for in another window
Toxicity and dose-response studies of 1,25-(OH)2-16-ene-23-yne vitamin D3 in transgenic mice.
C L Wilkerson; S R Darjatmoko; M J Lindstrom; D M Albert
View articletitled, Toxicity and dose-response studies of 1,25-(OH)2-16-ene-23-yne vitamin D3 in transgenic mice.
Open the PDF for in another window
Antimestatic and antitumor activities of interleukin 10 in transfected human prostate PC-3 ML clones: Orthotopic growth in severe combined immunodeficient mice.
M E Stearns; M Wang
View articletitled, Antimestatic and antitumor activities of interleukin 10 in transfected human prostate PC-3 ML clones: Orthotopic growth in severe combined immunodeficient mice.
Open the PDF for in another window
Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
D K Frank; T J Liu; M J Frederick; G L Clayman
View articletitled, Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
Open the PDF for in another window
Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma.
Y Oda; A Sakamoto; N Shinohara; T Ohga; T Uchiumi; K Kohno; M Tsuneyoshi; M Kuwano; Y Iwamoto
View articletitled, Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma.
Open the PDF for in another window
Immunohistochemical detection of multidrug resistance protein in human lung cancer and normal lung.
S R Wright; A H Boag; G Valdimarsson; D R Hipfner; B G Campling; S P Cole; R G Deeley
View articletitled, Immunohistochemical detection of multidrug resistance protein in human lung cancer and normal lung.
Open the PDF for in another window

Advertisement

Breaking
FDA Approves Drugs for MCL, Colorectal and Breast Cancers
NCI, NIH Directors Stepping Down
Pancreatic Cancer Survival Rate Stalls
View more recent articles
Latest News
Structural Variants Increase Risk of Pediatric Cancers
South Asian Scholars Urge Action on Cancer Inequities
Greater Certainty of Survival Valued Over Speedier Drug Access
View more recent articles
Research Watch
Bile Acids Modulate T-cell Response and Function in Liver Cancer
The Zinc-Binding Cysteine Proteome Comprises Targetable Cancer Vulnerabilities
Engineered Focal Oncogene Amplifications Drive Transformation and Progression
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept